MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid-Reference-Cited by-同舟云学术

MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid

Published:2022-09 Issue:9 Volume:129 Page:974-985
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Khanani Arshad M.^ORCID,Brown David M.^ORCID,Jaffe Glenn J.,Wykoff Charles C.^ORCID,Adiguzel Eser,Wong Randall,Meng Xiangyi,Heier Jeffrey S.^ORCID

Publisher

Elsevier BV

Subject

Ophthalmology

Reference31 articles.

2. Emerging therapies and their delivery for treating age-related macular degeneration;Thomas;Br J Pharmacol,2022

3. Ranibizumab versus verteporfin for neovascular age-related macular degeneration;Brown;N Engl J Med,2006

4. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

5. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration;Heier;Ophthalmology,2012

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation and Vasculitis Related to Brolucizumab;Journal of Clinical Medicine;2024-09-02

2. MERLIN: Two-Year Results of Brolucizumab in Participants With Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid;Ophthalmology;2024-09

3. Update on Retinal Drug Safety: Proceedings of the ASRS ReST Committee Webinar Part 1;Journal of VitreoRetinal Diseases;2024-08-22

4. Pro Re Nata brolucizumab for early onset and treatment-naïve diabetic macular edema: A prospective study;European Journal of Ophthalmology;2024-08-14

5. Incisional choroidal surgery;Survey of Ophthalmology;2024-08